BENDER LEWIS H has filed 4 insider transactions across 1 company since March 2024.
Most recent transaction: a grant/award of 37749 shares of INTENSITY THERAPEUTICS, INC. ($INTS) on March 26, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 26, 2026 | INTENSITY THERAPEUTICS, INC. | $INTS | BENDER LEWIS H | President and CEO | A | Common Stock, $0.0001 Par Value | 37749 | $6.11 | 118,549.0000 | 60,064,965 | 46.72% | 0.06% |
| May 2, 2025 | INTENSITY THERAPEUTICS, INC. | $INTS | BENDER LEWIS H | President and CEO | A | Stock Option (right to buy Common Stock) | 700000 | $0.00 | 700,000.0000 | 15,180,945 | 9999.99% | 4.61% |
| March 6, 2024 | INTENSITY THERAPEUTICS, INC. | $INTS | BENDER LEWIS H | President and CEO | A | Stock Option (right to buy Common Stock) | 464805 | $0.00 | 464,805.0000 | 0 | 9999.99% | 0.00% |
| March 6, 2024 | INTENSITY THERAPEUTICS, INC. | $INTS | BENDER LEWIS H | President and CEO | A | Stock Option (right to buy Common Stock) | 33574 | $0.00 | 33,574.0000 | 0 | 9999.99% | 0.00% |